Mobia Medical, Inc. (NASDAQ:MOBI) Stock Now Rated “Moderate Buy” by Wall Street Brokerages

Mobia Medical, Inc. (NASDAQ:MOBI) has been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $20.75.

Several brokerages have issued reports on MOBI. JPMorgan Chase & Co. boosted their target price on shares of Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. BTIG Research reaffirmed a “buy” rating and issued a $19.00 target price on shares of Mobia Medical in a research report on Tuesday, October 20th. Finally, Weiss Ratings began coverage on Mobia Medical in a report on Wednesday, August 12th. They set a “sell (e-)” rating on the stock.

Mobia Medical Price Performance

Shares of Mobia Medical stock opened at $11.28 on Friday. The company has a quick ratio of 12.80, a current ratio of 13.28 and a debt-to-equity ratio of 0.04. Mobia Medical has a 1-year low of $8.03 and a 1-year high of $15.29. The firm’s fifty day simple moving average is $9.99. The company has a market cap of $375.51 million and a P/E ratio of -0.56.

Mobia Medical (NASDAQ:MOBI) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.06). The firm had revenue of $15.62 million during the quarter. The firm’s revenue for the quarter was up 73.3% on a year-over-year basis. On average, research analysts expect that Mobia Medical will post -2.63 earnings per share for the current fiscal year.

Insider Activity at Mobia Medical

In other Mobia Medical news, Director Casey Tansey purchased 16,441 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were acquired at an average price of $12.07 per share, for a total transaction of $198,442.87. Following the acquisition, the director owned 318,332 shares of the company’s stock, valued at $3,842,267.24. This trade represents a 5.45% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last three months, insiders purchased 87,000 shares of company stock valued at $1,016,367.

Institutional Investors Weigh In On Mobia Medical

Several hedge funds and other institutional investors have recently made changes to their positions in MOBI. Citadel Advisors LLC acquired a new stake in shares of Mobia Medical during the 2nd quarter worth approximately $670,000. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Mobia Medical during the third quarter valued at approximately $1,019,000. State Street Corp bought a new stake in shares of Mobia Medical during the second quarter valued at approximately $735,000. Finally, Readystate Asset Management LP bought a new stake in shares of Mobia Medical during the second quarter valued at approximately $134,000.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.